Uterine cancer is the most common gynecologic cancer in the United States, and there are stark racial disparities that pervade the…

Many of the unique benefits you’ll find during the 2022 ONS Bridge conference come to you by way of the ONS Corporate Council, a group of top-…

You are cordially invited to join the presentation of Treatment Options for Patients with Resectable and Metastatic Non-Small Cell Lung Cancer on…

You are cordially invited to join the presentation of Treatment options for patients with Unresectable or Metastatic Melanoma, on Tuesday,…

Dorothy T. is a three-time cancer survivor who has endured debilitating side effects from chemotherapy that she described as “worse than…

Join PER® on 9/13 at 9:00 AM EDT for this complimentary CE-certified session on the Management of ER+ Breast Cancer. This live, virtual…

Genentech welcomes you to the 2022 virtual ONS Bridge™!

Please join us and presenter, Ellen Roth, for the Product Theater: “…

Join PER® on 9/15 at 9:00 AM EDT for this complimentary CE-certified session on the management of…

ONS Bridge is live on September 13 and 15, 2022, but our digital platform allows you to prepare for the conference today—and follow up…